Access Statistics for Darius Lakdawalla

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Aging and the Growth of Long-Term Care 0 0 0 30 0 0 4 144
Aging and the Growth of Long-Term Care 0 0 0 243 0 1 3 1,293
An Economic Evaluation of the War on Cancer 0 0 1 97 0 0 3 360
Are the Young Becoming More Disabled? 0 0 0 93 0 0 1 346
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk-Transfer 0 0 0 152 0 2 3 544
Does Medicare Benefit the Poor? New Answers to an Old Question 0 0 0 67 0 1 2 379
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 85 0 0 0 35
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 23 0 0 0 36
Economic Instruments for Obesity Prevention: Results of a Scoping Review and Modified Delphi Survey 0 0 0 55 0 0 2 257
Effects of Expanding Health Screening on Treatment - What Should We Expect? What Can We Learn? 0 0 0 6 0 1 5 42
Effects of expanding health screening on treatment – What should we expect? What can we learn? 0 0 0 6 0 0 1 54
Evaluation of Medical Technologies with Uncertain Benefits 0 0 0 48 0 2 2 45
Food Prices and the Dynamics of Body Weight 0 0 0 71 0 0 1 232
HIV Breakthroughs and Risk Sexual Behavior 0 0 0 84 0 1 1 635
Healing the Poor: The Influence of Patient Socioeconomic Status on Physician Supply Responses 0 0 0 13 0 0 1 53
Health Insurance as a Two-Part Pricing Contract 0 0 0 97 1 3 5 428
Health and Access Effects of New Drugs: Combining Experimental and Non-Experimental Data 0 0 0 52 0 0 0 191
Insurance and Innovation in Health Care Markets 0 0 2 138 0 1 3 468
Insurance, Self-Protection, and the Economics of Terrorism 0 0 0 289 0 0 0 886
Insurer Bargaining and Negotiated Drug Prices in Medicare Part D 0 0 0 32 0 0 0 148
Insurers' Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 14 0 1 1 97
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 3 1 1 3 72
Intellectual Property and Marketing 0 0 0 0 1 3 5 6
Intellectual Property and Marketing 0 0 0 91 2 2 7 392
International Differences in Longevity and Health and Their Economic Consequences 0 0 0 35 0 0 0 122
International Differences in Longevity and Health and their Economic Consequences 0 0 1 55 0 2 3 170
International Differences in Longevity and Health and their Economic Consequences 0 0 0 51 0 1 1 264
Mortality Risk, Insurance, and the Value of Life 0 0 0 37 0 0 2 48
Nonprofit Production 0 0 0 0 0 1 1 196
Nonprofit Production and Competition 1 1 1 300 2 2 3 1,255
Optimal Liability for Terrorism 0 0 0 40 0 1 4 215
Prescription Drug Advertising and Drug Utilization: The Role of Medicare Part D 0 0 1 24 0 0 1 96
Risk Preferences Over Health: Empirical Estimates and Implications for Healthcare Decision-Making 0 0 1 15 0 0 1 9
The Declining Quality of Teachers 0 0 1 222 0 2 9 1,699
The Effect of US COVID-19 Excess Mortality on Social Security Outlays 1 6 6 6 2 5 5 5
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 1 89 0 2 6 371
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 0 0 0 1 3 5
The Growth of Obesity and Technological Change: A Theoretical and Empirical Examination 0 0 1 492 0 0 4 1,603
The Insurance Value of Medical Innovation 0 1 1 34 0 1 4 106
The Rise in Old Age Longevity and the Market for Long-Term Care 0 1 2 3 0 2 3 771
The Rise in Old Age Longevity and the Market for Long-Term Care 0 0 0 234 0 0 1 1,775
The Value of Medican and Pharmaceutical Interventions for Reducing Obesity 0 0 0 29 0 1 4 165
The Welfare Effects of Medical Malpractice Liability 0 0 0 101 0 7 10 474
The Welfare Effects of Public Drug Insurance 0 0 0 77 0 1 2 287
Time-Inconsistency and Welfare 0 0 0 79 0 0 1 377
Understanding Health Disparities Across Education Groups 0 1 6 398 0 5 15 1,701
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 50 0 1 1 178
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 0 36 0 0 0 111
Understanding the Economic Consequences of Shifting Trends in Population Health 0 0 1 43 1 2 3 225
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market 0 0 0 15 0 0 3 108
Vaccine Allocation Priorities Using Disease Surveillance and Economic Data 0 0 0 2 0 0 0 14
Total Working Papers 2 10 26 4,256 10 56 143 19,493


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
A Cost-Benefit Analysis of Using Evidence of Effectiveness in Terms of Progression Free Survival in Making Reimbursement Decisions on New Cancer Therapies 0 0 1 57 0 1 2 215
A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis 0 0 0 2 0 0 0 19
A Theory of Health Disparities and Medical Technology 0 2 6 145 0 6 16 612
A guide to extending and implementing generalized risk-adjusted cost-effectiveness (GRACE) 0 0 0 2 0 0 1 20
A principled approach to non-discrimination in cost-effectiveness 0 0 0 0 0 1 1 1
An economic evaluation of the war on cancer 0 0 4 108 0 2 11 580
Are Biopharmaceutical Budget Caps Good Public Policy? 0 0 0 12 0 0 0 72
Are investments in disease prevention complements? The case of statins and health behaviors 0 0 0 11 0 0 2 79
Can Oral Nutritional Supplements Improve Medicare Patient Outcomes in the Hospital? 0 0 0 35 0 0 1 179
Can the ACA Improve Population Health? 0 0 1 14 0 0 2 68
Catastrophe Bonds, Reinsurance, and the Optimal Collateralization of Risk Transfer 0 2 3 19 0 3 4 105
Differences in health between Americans and Western Europeans: Effects on longevity and public finance 0 0 1 27 0 1 3 108
Disability Forecasts and Future Medicare Costs 0 0 0 34 0 0 1 272
Does Intellectual Property Restrict Output? An Analysis of Pharmaceutical Markets 0 0 0 40 0 1 2 169
Does Medicare Coverage Improve Cancer Detection and Mortality Outcomes? 0 0 0 2 0 1 2 17
Does Medicare benefit the poor? 0 0 3 139 0 1 5 341
Economics of the Pharmaceutical Industry 0 4 6 309 0 6 19 700
Erratum: Valuing health technologies at NICE: recommendations for improved incorporation of treatment value in HTA 0 0 0 3 0 0 0 20
Geographic Variation in Health Care: The Role of Private Markets 0 0 0 75 0 2 4 419
HIV Breakthroughs and Risky Sexual Behavior 0 0 0 166 4 6 8 917
HOW DOES HEALTH INSURANCE AFFECT WORKERS’ COMPENSATION FILING? 0 0 0 15 0 0 3 284
HOW DOES TERRORISM RISK VARY ACROSS SPACE AND TIME? AN ANALYSIS BASED ON THE ISRAELI EXPERIENCE 0 0 3 99 0 1 7 311
Healing the poor: The influence of patient socioeconomic status on physician supply responses 0 0 0 3 2 2 3 68
Health insurance as a two-part pricing contract 0 0 0 49 1 2 3 360
Health technology assessment with risk aversion in health 0 0 1 9 1 2 5 46
Innovation and the welfare effects of public drug insurance 0 2 3 45 0 3 8 158
Insurance, self-protection, and the economics of terrorism 0 0 1 81 0 1 3 315
Insurers’ Negotiating Leverage and the External Effects of Medicare Part D 0 0 0 16 0 0 4 135
Is nursing home demand affected by the decline in age difference between spouses? 0 0 0 26 0 1 1 324
Labor Supply and Weight 0 0 2 49 0 0 3 136
Patient Outcomes and Cost Effects of Medicaid Formulary Restrictions on Antidepressants 0 0 1 49 1 3 6 184
Pharmaceutical advertising and Medicare Part D 0 0 0 12 0 1 2 147
Predicting quantity and quality of life with the Future Elderly Model 0 0 0 2 0 2 2 13
Prescription drug advertising and drug utilization: The role of Medicare Part D 0 0 1 2 0 2 6 14
Public Financing and the Market for Long-Term Care 0 0 0 24 0 0 0 99
Public-Private Partnership as a Path to Affordable Healthcare in Emerging Markets 0 0 0 14 1 2 3 95
Quantifying Gains in the War on Cancer Due to Improved Treatment and Earlier Detection 0 0 2 41 0 0 10 153
Risk preferences over health: Empirical estimates and implications for medical decision-making 0 0 1 1 1 2 5 5
Social insurance and the design of innovation incentives 0 0 0 20 0 0 2 87
The Contributions of Improved Therapy and Earlier Detection to Cancer Survival Gains, 1988-2000 0 0 1 72 0 0 4 296
The Economics of Teacher Quality 0 0 0 6 1 1 1 218
The Fiscal Consequences of Trends in Population Health 0 0 0 15 0 0 0 65
The Generalized Risk-Adjusted Cost-Effectiveness (GRACE) Model for Measuring the Value of Gains in Health: An Exact Formulation 0 0 0 3 1 3 5 21
The Labor Market Value of Health Improvements 0 1 1 45 0 1 1 152
The Rise in Old-Age Longevity and the Market for Long-Term Care 0 0 0 106 0 3 4 443
The Social Value of Improvement in Activities of Daily Living among the Advanced Parkinson’s Disease Population 0 0 0 2 0 0 1 21
The Value of Diagnostic Testing in Personalized Medicine 0 0 0 60 4 5 5 223
The economics of alternative payment models for pharmaceuticals 0 0 1 9 0 1 3 38
The growth of obesity and technological change 0 0 0 32 0 1 7 136
The insurance value of medical innovation 0 0 3 41 0 0 10 169
The nonprofit sector and industry performance 0 0 2 255 2 2 9 706
The role of imperfect surrogate endpoint information in drug approval and reimbursement decisions 0 0 0 4 0 0 2 47
The value of medical and pharmaceutical interventions for reducing obesity 0 0 0 15 0 1 4 97
The welfare effects of medical malpractice liability 0 0 0 15 0 3 7 150
Unintended Consequences of Products Liability: Evidence from the Pharmaceutical Market* 0 0 0 0 1 3 7 9
Valuing health technologies at nice: recommendations for improved incorporation of treatment value in HTA 0 0 0 26 0 0 0 100
Valuing the Societal Impact of Medicines and Other Health Technologies: A User Guide to Current Best Practices 0 1 1 1 0 4 5 5
Want More Value from Prescription Drugs? We Need to Let Prices Rise and Fall 0 0 1 1 0 2 3 17
Welfare-Enhancing Technological Change and the Growth of Obesity 0 1 1 152 0 3 4 428
Total Journal Articles 0 13 51 2,617 20 88 242 11,188


Chapter File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Disability Forecasts and Future Medicare Costs 0 0 0 23 1 2 2 107
Economics of Obesity 0 1 2 25 0 2 5 91
Economics of Obesity 0 0 0 37 0 2 4 98
Food Prices and the Dynamics of Body Weight 0 0 0 14 0 0 2 72
Intellectual Property, Information Technology, Biomedical Research, and Marketing of Patented Products 2 3 9 101 5 9 20 256
Medical Care Output and Productivity in the Nonprofit Sector 0 0 0 12 0 0 0 62
Patents, innovation, and the welfare effects of Medicare Part D 0 0 0 0 0 0 1 1
Public Financing and the Market for Long-Term Care 0 0 0 8 0 2 3 52
Total Chapters 2 4 11 220 6 17 37 739


Statistics updated 2025-05-12